American Association for Cancer Research

Table 5

Uterine weights of immature rats treated with AN in treatment groups

Treatment group	s.c. injections	Administered p.o.	n	Relative uterine weight (mg/100 g bw)
Control^a	Oil	Oil	7	41 ± 3^b
Positive control^c	AN 30 mg/kg	Oil	13	119 ± 51^a
Aromatase inhibitor	AN 30 mg/kg	Finrozole 10 mg/kg	9	67 ± 19^c
ENL	AN 30 mg/kg	ENL 50 mg/kg	9	119 ± 35^a
MR	AN 30 mg/kg	MAT 50 mg/kg	4	146 ± 29^a
SECO	AN 30 mg/kg	SECO 50 mg/kg	5	135 ± 22^a
HMR	AN 30 mg/kg	HMR 50 mg/kg	10	102 ± 14^a

Treatment group	s.c. injections	Administered p.o.	n	Relative uterine weight (mg/100 g bw)
Control^a	Oil	Oil	7	41 ± 3^b
Positive control^c	AN 30 mg/kg	Oil	13	119 ± 51^a
Aromatase inhibitor	AN 30 mg/kg	Finrozole 10 mg/kg	9	67 ± 19^c
ENL	AN 30 mg/kg	ENL 50 mg/kg	9	119 ± 35^a
MR	AN 30 mg/kg	MAT 50 mg/kg	4	146 ± 29^a
SECO	AN 30 mg/kg	SECO 50 mg/kg	5	135 ± 22^a
HMR	AN 30 mg/kg	HMR 50 mg/kg	10	102 ± 14^a

^a–c

Relative weights with the different letters ^{a, b,} and ^c indicate statistically significant differences (P < 0.05) between the treatment groups tested by Kruskal-Wallis median test followed by Mann-Whitney U test.

View Large

This Feature Is Available To Subscribers Only